z-logo
open-access-imgOpen Access
Psychopharmacology of schizophrenia: The future looks bleak
Author(s) -
Chittaranjan Andrade,
Rajiv Radhakrishnan,
Praveen Fernandes
Publication year - 2012
Publication title -
mens sana monographs
Language(s) - English
Resource type - Journals
eISSN - 0973-1229
pISSN - 1998-4014
DOI - 10.4103/0973-1229.91293
Subject(s) - schizophrenia (object oriented programming) , dopamine hypothesis of schizophrenia , pharmacotherapy , psychiatry , neurotransmitter systems , psychopharmacology , neuroscience , psychology , medicine , dopamine , psychotherapist , dopamine receptor
More than half a century after the introduction of effective pharmacotherapy for the illness, in most patients schizophrenia remains a chronic, relapsing condition with poor long-term outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here